Enzene Inaugurates First U.S. Biomanufacturing Facility with Governor Phil Murphy in New Jersey

  Governor Phil Murphy officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leading global continuously innovative deve...

September 10, 2025 | Wednesday | News
NurExone Biologic Secures US Patent Allowance for Proprietary Exosome Production Process Strengthening Global Market Position

NurExone Biologic Inc. , a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the United S...

September 09, 2025 | Tuesday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
New Jersey: A Leading Life Sciences Manufacturing Hub

New Jersey at a Glance – Often dubbed the “Medicine Chest of the World,” New Jersey has a rich legacy and a dynamic present as a global h...

September 03, 2025 | Wednesday | Reports
MEDIPAL and JCR Partner on Global Development of JR-479 for Ultra-Rare GM2 Gangliosidosis

MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced that the two companies have signed an exclus...

September 03, 2025 | Wednesday | News
Thermo Fisher Finalises $4B Solventum Filtration Deal Expanding Bioprocessing Portfolio and Adjacent Markets

Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the w...

September 03, 2025 | Wednesday | News
Roche and Alnylam Target Uncontrolled Hypertension with ZENITH Phase III Trial

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KA...

September 02, 2025 | Tuesday | News
LOTTE BIOLOGICS Expands U.S. Footprint with Third Contract in 2025

Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships LOTTE BIOLOGICS (CEO James Park) announce...

September 02, 2025 | Tuesday | News
Imbed Biosciences Launches SAM™ PainGuard™ with Lidocaine for Surgical, Burn, and Trauma Wound Care

 Imbed Biosciences Inc., a leader in advanced wound care technology,  announced the launch of SAM™ PainGuard™ with Lidocaine, ...

August 29, 2025 | Friday | News
CAGE Bio and Mayo Clinic Collaborate to Develop Novel Therapies for Chronic Graft-Versus-Host Disease

CAGE Bio Inc., a leader in advancing innovative therapies for targeted and localized treatment of immunological skin diseases, today announced it has ent...

August 28, 2025 | Thursday | News
Hongene Biotech (China) Partners with UMass Chan (US) to Supply exNA Oligonucleotides for Research

Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) specializing in nucleic acid therapeutics, entered a non-exclus...

August 27, 2025 | Wednesday | News
Neopharma Technologies and Orient Gene Announce Global Partnership to Digitize Drug Testing with NEOVAULT® Integration

Neopharma Technologies Limited  announced a global software licensing and collaboration agreement with Zhejiang Orient Gene Biotech Co., Ltd. ("Orie...

August 26, 2025 | Tuesday | News
Innovent Biologics Receives FDA Clearance to Launch First Global Phase 3 Trial of IBI363 in IO-Resistant Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing h...

August 25, 2025 | Monday | News
BlossomHill Therapeutics Doses First Patient in SOLARA Trial Expansion of First-in-Class OMNI-EGFR™ Inhibitor

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines ...

August 25, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close